Over the past 12‑18 months, the Diglycolamine market has witnessed a cluster of strategic moves that are reshaping the competitive landscape. In March 2024, BASF entered a global partnership with Clariant to co‑develop high‑purity diglycolamine catalysts for CO₂ capture, accelerating technology transfer across Europe and Asia. Meanwhile, Eastman Chemical completed its acquisition of Cymbalta Specialty, adding a downstream purification platform and expanding its capacity by 30 %. In July 2024, Solvay launched a next‑generation, low‑odor diglycolamine formulation designed for automotive paint stripping, which promises a 15 % reduction in VOC emissions. Regulatory momentum also intensified: the European Union’s REACH amendment, effective January 2025, mandates stricter reporting on nitrogen‑containing amines, prompting manufacturers to upgrade compliance systems. On the demand side, OEMs are shifting toward greener solvent blends, driving a 12 % YoY increase in diglycolamine shipments for metal cleaning. Finally, Blue Sky Ventures led a $45 million Series B round for NovaChem, enabling a new 200‑tonne per annum production line in Texas. These developments illustrate the dynamic Diglycolamine industry trends shaping growth through innovation, consolidation, and sustainability.
